

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb265</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Association of ATP-Binding Cassette Transporter A1 (&lt;i&gt;ABCA1&lt;/i&gt;)-565 C/T Gene  Polymorphism with Hypoalphalipoproteinemia and Serum Lipids, IL-6 and CRP Levels</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Babashamsi</surname><given-names>Mohammad Mahdi</given-names></name></contrib><aff>Psychiatric Research Center, Roozbeh Hospital, South Kargar Street, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Halalkhor</surname><given-names>Sohrab</given-names></name></contrib><aff>Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Moradi Firouzjah</surname><given-names>Hamid</given-names></name></contrib><aff>Cellular and Molecular Research Center, Taleghani Children Hospital, Gorgan University of Medical Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Parsian</surname><given-names>Hadi</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Jalali</surname><given-names>Seyed Farzad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Babashamsi</surname><given-names>Mohammad</given-names></name></contrib><aff>Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences      , Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>1</issue>
      <fpage>38</fpage>
      <lpage>43</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: ATP-binding cassette transporter A1 (&lt;em&gt;ABCA1&lt;/em&gt;) is a membrane integral protein which plays a vital role in High Density Lipoprotein (HDL) metabolism and exerts a protective effect against Hypoalphalipoproteinemia (HA) by mediation of rate-limiting step in HDL biogenesis. In addition, this protein possesses anti-inflammatory effects by inhibiting the production of some inflammatory cytokines in macrophages. This study investigated the association of &lt;em&gt;ABCA1&lt;/em&gt;-565 C/T gene polymorphism with HA and serum lipids, IL-6 and CRP levels.&lt;br /&gt;
Methods: A population which consisted of 101 HA and 95 normal subjects were genotyped for &lt;em&gt;ABCA1&lt;/em&gt;-565C/T polymorphism by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). The serum concentrations of lipids, IL-6 and high sensitive-CRP (hs-CRP) were measured by the relevant methods.&lt;br /&gt;
Results: The frequency of T allele was significantly higher in the HA group than the controls (31.7 &lt;em&gt;vs&lt;/em&gt;. 19.5%, p=0.002). Thus, carriers of the T allele (CT and TT genotypes) had a higher risk for HA (p=0.016, OR=2.04, 95% CI=1.14-3.63). T allele carriers demonstrated decreased HDL-C and increased triglyceride, IL-6 and CRP levels than those with the CC genotype. &amp;nbsp;&lt;br /&gt;
Conclusion: This study suggests that the-565 C/T polymorphism of &lt;em&gt;ABCA1&lt;/em&gt; gene is associated with an increased risk of HA, decreased HDL-C and increased TG, IL-6 and CRP.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
